ATX01
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ATX01, covering 2024-04-18 to 2024-07-16. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of ATX01 in Adult Patients With CIPN (Chemotherapy-induced Peripheral Neuropathy) [Phase 2]